Market Place
Sourcing Support
All News #Library
Sciences
89% of HIV Patients Choose ViiV’s Long-Acting Injection
14 Jul 2025 //
BUSINESSWIRE
ViiV Health Expand Data on Long-Acting HIV Therapies at HIV Glasgow
07 Nov 2024 //
BUSINESSWIRE
ViiV Healthcare announces FDA Approval of Dovato for Adolescents Living with HIV
08 Apr 2024 //
BUSINESSWIRE
ViiV Healthcare Announces Data at CROI Indicating Efficacy of Cabenuva
06 Mar 2024 //
BUSINESSWIRE
ViiV Healthcare receives approval from China’s NMPA for Vocabria
27 Oct 2023 //
PRESS RELEASE
ViiV Healthcare to present 23 abstracts from innovative HIV treatment
18 Oct 2023 //
BUSINESSWIRE
GSK and ViiV Healthcare to present scientific advancements at IDWeek 2023
10 Oct 2023 //
PRESS RELEASE
GSK`s ViiV Healthcare takes Shutterstock-partnered campaign in new direction
21 Sep 2023 //
ENDPTS
GSK`s ViiV, Pfizer and Roche score high with patient groups
27 Apr 2022 //
FIERCEPHARMA
FierceMadness winner Dovato shows full picture of HIV patients
09 Apr 2021 //
FIERCEPHARMA
Long-lasting HIV injection is a step closer after second GSK study
31 Oct 2018 //
REUTERS
Two Drugs as Good as Three for Treating HIV
25 Jul 2018 //
LABIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.